Surprisingly, we observed signs of protection from FSGS, including a reduction in podocyte foot process effacement and pro-fibrotic TGF-β expression (Fig. 6 and supplementary material Fig. S4). Here, TGFB1 is linked to focal segmental glomerulosclerosis.